M Trovati

Summary

Affiliation: University of Turin
Country: Italy

Publications

  1. pmc Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study
    Franco Cavalot
    Medicine and Metabolic Disease Unit, Department of Clinical and Biological Sciences, San Luigi Gonzaga Faculty of Medicine of Turin University, San Luigi Gonzaga Hospital, Turin, Italy
    Diabetes Care 34:2237-43. 2011
  2. pmc Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells
    Giovanni Anfossi
    Department of Clinical and Biological Sciences, Internal Medicine and Metabolic Disease Unit, San Luigi Gonzaga Hospital, San Luigi Gonzaga Faculty of Medicine of the Turin University, Orbassano, 10043 Turin, Italy
    Mediators Inflamm 2010:174341. 2010
  3. ncbi Leptin and vascular smooth muscle cells
    Mariella Trovati
    Internal Medicine and Metabolic Disease Unit, Department of Clinical and Biological Sciences of the Turin University, San Luigi Gonzaga Hospital, I 10043 Orbassano Turin, Italy
    Curr Pharm Des 20:625-34. 2014
  4. pmc Oleic acid increases synthesis and secretion of VEGF in rat vascular smooth muscle cells: role of oxidative stress and impairment in obesity
    Gabriella Doronzo
    Internal Medicine and Metabolic Disease Unit, Department of Clinical and Biological Sciences of the University of Turin, San Luigi Gonzaga Hospital, Orbassano Turin 10043, Italy
    Int J Mol Sci 14:18861-80. 2013
  5. pmc High glucose inhibits the aspirin-induced activation of the nitric oxide/cGMP/cGMP-dependent protein kinase pathway and does not affect the aspirin-induced inhibition of thromboxane synthesis in human platelets
    Isabella Russo
    Internal Medicine and Metabolic Disease Unit, San Luigi Gonzaga Hospital, Department of Clinical and Biological Sciences, San Luigi Gonzaga School of Medicine, University of Turin, Turin, Italy
    Diabetes 61:2913-21. 2012
  6. ncbi Mechanisms involved in platelet hyperactivation and platelet-endothelium interrelationships in diabetes mellitus
    Mariella Trovati
    Diabetes Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, Orbassano 10043, Turin, Italy
    Curr Diab Rep 2:316-22. 2002
  7. ncbi Afternoon hypoglycaemia in Type 2 diabetes: lessons from blood glucose profiles
    M Trovati
    Diabetes Unit, Department of Clinical and Biological Sciences of the University of Turin, San Luigi Gonzaga Hospital, 10043 Orbassano, Turin, Italy
    Diabetes Nutr Metab 15:439-43. 2002
  8. ncbi Blood glucose pre-prandial baseline decreases from morning to evening in type 2 diabetes: role of fasting blood glucose and influence on post-prandial excursions
    M Trovati
    Diabetes Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, 10043 Orbassano, Turin, Italy
    Eur J Clin Invest 32:179-86. 2002
  9. ncbi Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function
    Mariella Trovati
    Metabolic Disease and Diabetes Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital 10043, Orbassano Torino, Italy
    J Diabetes Complications 16:35-40. 2002
  10. ncbi Optimization of hypolipidemic and antiplatelet treatment in the diabetic patient with renal disease
    Mariella Trovati
    Diabetes Unit, Department of Clinical and Biological Sciences, Turin University, San Luigi Gonzaga Hospital, Torino, Italy
    J Am Soc Nephrol 15:S12-20. 2004

Collaborators

Detail Information

Publications50

  1. pmc Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study
    Franco Cavalot
    Medicine and Metabolic Disease Unit, Department of Clinical and Biological Sciences, San Luigi Gonzaga Faculty of Medicine of Turin University, San Luigi Gonzaga Hospital, Turin, Italy
    Diabetes Care 34:2237-43. 2011
    ..To evaluate whether postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a long-term follow-up taking into account A1C and the main cardiovascular risk factors...
  2. pmc Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells
    Giovanni Anfossi
    Department of Clinical and Biological Sciences, Internal Medicine and Metabolic Disease Unit, San Luigi Gonzaga Hospital, San Luigi Gonzaga Faculty of Medicine of the Turin University, Orbassano, 10043 Turin, Italy
    Mediators Inflamm 2010:174341. 2010
    ....
  3. ncbi Leptin and vascular smooth muscle cells
    Mariella Trovati
    Internal Medicine and Metabolic Disease Unit, Department of Clinical and Biological Sciences of the Turin University, San Luigi Gonzaga Hospital, I 10043 Orbassano Turin, Italy
    Curr Pharm Des 20:625-34. 2014
    ....
  4. pmc Oleic acid increases synthesis and secretion of VEGF in rat vascular smooth muscle cells: role of oxidative stress and impairment in obesity
    Gabriella Doronzo
    Internal Medicine and Metabolic Disease Unit, Department of Clinical and Biological Sciences of the University of Turin, San Luigi Gonzaga Hospital, Orbassano Turin 10043, Italy
    Int J Mol Sci 14:18861-80. 2013
    ..Thus, in OZR chronically elevated oxidative stress causes a resistance to the action on VEGF that OA exerts in LZR by increasing ROS. ..
  5. pmc High glucose inhibits the aspirin-induced activation of the nitric oxide/cGMP/cGMP-dependent protein kinase pathway and does not affect the aspirin-induced inhibition of thromboxane synthesis in human platelets
    Isabella Russo
    Internal Medicine and Metabolic Disease Unit, San Luigi Gonzaga Hospital, Department of Clinical and Biological Sciences, San Luigi Gonzaga School of Medicine, University of Turin, Turin, Italy
    Diabetes 61:2913-21. 2012
    ..These results identify a mechanism by which high glucose interferes with the aspirin action...
  6. ncbi Mechanisms involved in platelet hyperactivation and platelet-endothelium interrelationships in diabetes mellitus
    Mariella Trovati
    Diabetes Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, Orbassano 10043, Turin, Italy
    Curr Diab Rep 2:316-22. 2002
    ....
  7. ncbi Afternoon hypoglycaemia in Type 2 diabetes: lessons from blood glucose profiles
    M Trovati
    Diabetes Unit, Department of Clinical and Biological Sciences of the University of Turin, San Luigi Gonzaga Hospital, 10043 Orbassano, Turin, Italy
    Diabetes Nutr Metab 15:439-43. 2002
  8. ncbi Blood glucose pre-prandial baseline decreases from morning to evening in type 2 diabetes: role of fasting blood glucose and influence on post-prandial excursions
    M Trovati
    Diabetes Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, 10043 Orbassano, Turin, Italy
    Eur J Clin Invest 32:179-86. 2002
    ..We aimed to clarify: (a) whether BG preprandial baseline is stable also in type 2 diabetes and (b) whether fasting BG (FBG) influences the slope of BG preprandial baseline and the relationships between pre- and postprandial BG...
  9. ncbi Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function
    Mariella Trovati
    Metabolic Disease and Diabetes Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital 10043, Orbassano Torino, Italy
    J Diabetes Complications 16:35-40. 2002
    ....
  10. ncbi Optimization of hypolipidemic and antiplatelet treatment in the diabetic patient with renal disease
    Mariella Trovati
    Diabetes Unit, Department of Clinical and Biological Sciences, Turin University, San Luigi Gonzaga Hospital, Torino, Italy
    J Am Soc Nephrol 15:S12-20. 2004
    ..Finally, dyslipidemia contributes to the deterioration of renal function, a phenomenon potentially prevented by hypolipidemic therapy...
  11. ncbi Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress
    I Russo
    Diabetes Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, 10043 Orbassano TO, Italy
    Endocrinology 149:1480-9. 2008
    ..Antioxidants partially prevented the defects of the NO/cGMP/PKG pathway observed in VSMCs from OZR, which were reproduced by hydrogen peroxide in VSMCs from LZR, suggesting the pivotal role of oxidative stress...
  12. ncbi Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content
    G Anfossi
    Diabetes Unit, Department of Clinical and Biological Sciences, University of Turin, Azienda Ospedaliera S. Luigi, I-10043 Orbassano, Turin, Italy
    Thromb Res 102:319-30. 2001
    ..Furthermore, they indicated a role of cAMP accumulation in the antiaggregating effects of nitroso donor: the simultaneous increase of intracellular content of cAMP and cGMP can synergize in the reduction of the platelet responses...
  13. ncbi Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance
    G Doronzo
    University of Turin, Turin, Italy
    Eur J Clin Invest 34:664-73. 2004
    ....
  14. ncbi Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study
    F Cavalot
    Diabetes Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, 10043 Orbassano Turin, Italy
    J Clin Endocrinol Metab 91:813-9. 2006
    ..We aimed to evaluate the predictive role of both fasting and postprandial blood glucose on cardiovascular events in type 2 diabetes and the influence of gender...
  15. ncbi Platelet dysfunction in central obesity
    G Anfossi
    Diabetes Unit, Department of Clinical and Biological Sciences of the Turin University, San Luigi Gonzaga Hospital, Orbassano I 10043, Turin, Italy
    Nutr Metab Cardiovasc Dis 19:440-9. 2009
    ..Thus, a specifically tailored antiaggregating therapy is likely necessary in obese, insulin resistant subjects, especially in the presence of type 2 diabetes mellitus...
  16. ncbi A comparison of the predictive power for overall blood glucose control of a 'good' fasting level in type 2 diabetic patients on diet alone or with oral agents
    M Trovati
    Department of Clinical and Biological Sciences, University of Torino, San Luigi Gonzaga Hospital, Orbassano, Italy
    Diabet Med 9:134-7. 1992
    ..6 +/- 0.1 vs 5.9 +/- 0.1%, p less than 0.001), and correlated with the mean blood glucose concentration (r = 0.43, p less than 0.001) but not with the fasting glucose concentrations.(ABSTRACT TRUNCATED AT 250 WORDS)..
  17. ncbi Insulin activates hypoxia-inducible factor-1alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling
    G Doronzo
    Diabetes Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, I 10043, Orbassano, Turin, Italy
    Diabetologia 49:1049-63. 2006
    ....
  18. doi In central obesity, weight loss restores platelet sensitivity to nitric oxide and prostacyclin
    Isabella Russo
    Department of Clinical and Biological Sciences, Internal Medicine Unit, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Italy
    Obesity (Silver Spring) 18:788-97. 2010
    ..Thus, in central obesity, diet-induced weight loss reduces platelet activation and restores the sensitivity to the physiological antiaggregating agents, with a correlation with improvements in insulin sensitivity...
  19. ncbi Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity
    G Anfossi
    Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy
    Eur J Clin Invest 34:482-9. 2004
    ....
  20. doi The incidence of type 1 diabetes is increasing in both children and young adults in Northern Italy: 1984-2004 temporal trends
    G Bruno
    Department of Internal Medicine, University of Turin, Corso Dogliotti 14, 10126, Turin, Italy
    Diabetologia 52:2531-5. 2009
    ..We aimed to test this hypothesis by assessing trends in incidence rates in the period 1984-2004 in children and young adults in Northern Italy...
  21. ncbi Insulin, at physiological concentrations, enhances the polymorphonuclear leukocyte chemotactic properties
    F Cavalot
    Department of Clinical and Biological Sciences, University of Torino, San Luigi Gonzaga Hospital, Italy
    Horm Metab Res 24:225-8. 1992
    ..Our data show that insulin affects PMN activity in normal subjects and therefore support the hypothesis that insulin deficiency may be responsible for the impaired PMN function observed in diabetic patients in poor metabolic control...
  22. ncbi Comparison between the effects of the rapid recombinant insulin analog Lispro (Lys B28, Pro B29) and those of human regular insulin on platelet cyclic nucleotides and aggregation
    Isabella Russo
    Diabetes Unit, Department of Clinical and Biological Sciences of the University of Turin, San Luigi Gonzaga Hospital, 10043 Orbassano, Turin, Italy
    Thromb Res 109:323-7. 2003
  23. ncbi Insulin influences the nitric oxide cyclic nucleotide pathway in cultured human smooth muscle cells from corpus cavernosum by rapidly activating a constitutive nitric oxide synthase
    Giovanni Anfossi
    Diabetes Unit, Department of Clinical and Biological Sciences of the University of Turin, San Luigi Gonzaga Hospital, 10043 Orbassano, Turin, Italy
    Eur J Endocrinol 147:689-700. 2002
    ....
  24. ncbi Comparison between the effects of the rapid recombinant insulin analog aspart and those of human regular insulin on platelet cyclic nucleotides and aggregation
    Isabella Russo
    Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, 10043 Orbassano, Turin, Italy
    Thromb Res 107:31-7. 2002
    ..027). CONCLUSIONS: The effects of insulin aspart on platelet cyclic nucleotides and aggregation show kinetic differences compared to those of human regular insulin, resulting in more prolonged effects...
  25. ncbi Platelet resistance to the antiaggregatory cyclic nucleotides in central obesity involves reduced phosphorylation of vasodilator-stimulated phosphoprotein
    Isabella Russo
    Diabetes Unit, Department of Clinical and Biological Sciences of University of Turin, San Luigi Gonzaga Hospital, Orbassano Turin, Italy
    Clin Chem 53:1053-60. 2007
    ..In this study we evaluated whether this impairment involves the antiaggregatory pathways regulated by cAMP and cGMP...
  26. ncbi Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells
    L Bergandi
    Department of Genetics, Biology and Biochemistry, University of Turin, Italy
    Arterioscler Thromb Vasc Biol 23:2215-21. 2003
    ..The aim of the present study was to determine whether in these cells the insulin-stimulated NO/cyclic GMP pathway plays a role in the regulation of glucose uptake...
  27. ncbi Platelet resistance to the anti-aggregating agents in the insulin resistant states
    Giovanni Anfossi
    Diabetes Unit, Department of Clinical and Biological Sciences of the University of Turin, San Luigi Gonzaga Hospital, 10043 Orbassano Turin, Italy
    Curr Diabetes Rev 2:409-30. 2006
    ..Thus, in the second part of this review we performed a critical overview of the clinical trials on anti-aggregating agents carried out in subjects with metabolic syndrome and type 2 diabetes mellitus...
  28. ncbi Platelet resistance to the antiaggregating effect of N-acetyl-L-cysteine in obese, insulin-resistant subjects
    Giovanni Anfossi
    Diabetes Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, I 10043 Orbassano, Turin, Italy
    Thromb Res 110:39-46. 2003
    ....
  29. ncbi The cardiovascular effects of metformin: further reasons to consider an old drug as a cornerstone in the therapy of type 2 diabetes mellitus
    Giovanni Anfossi
    Internal Medicine III University Unit, San Luigi Gonzaga Faculty of Medicine and Department of Clinical and Biological Sciences of the Turin University, San Luigi Gonzaga Hospital, 10043 Orbassano Turin, Italy
    Curr Vasc Pharmacol 8:327-37. 2010
    ..Furthermore, the molecular mechanisms of the beneficial metabolic and vascular effects of metformin will be considered, with a particular attention for its ability to activate AMP-activated protein kinase...
  30. ncbi Pathophysiology of platelet resistance to anti-aggregating agents in insulin resistance and type 2 diabetes: implications for anti-aggregating therapy
    Giovanni Anfossi
    Diabetes Unit, Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga Hospital, I 10043 Orbassano Turin, Italy
    Cardiovasc Hematol Agents Med Chem 4:111-28. 2006
    ..Thus, in the second part of this review we carried out a critical overview of the clinical trials in subjects with metabolic syndrome and type 2 diabetes mellitus with or without macroangiopathy...
  31. ncbi Resistance to aspirin and thienopyridines in diabetes mellitus and metabolic syndrome
    Giovanni Anfossi
    Diabetes Unit, Department of Clinical and Biological Sciences of the University of Turin, San Luigi Gonzaga Hospital, 10043 Orbassano Turin, Italy
    Curr Vasc Pharmacol 6:313-28. 2008
    ....
  32. doi Role of NMDA receptor in homocysteine-induced activation of mitogen-activated protein kinase and phosphatidyl inositol 3-kinase pathways in cultured human vascular smooth muscle cells
    Gabriella Doronzo
    Metabolic Disease and Diabetes Unit, Department of Clinical and Biological Sciences of the University of Turin, San Luigi Gonzaga Hospital, Orbassano Turin, Italy
    Thromb Res 125:e23-32. 2010
    ..One possible receptor is N-methyl-D-aspartate receptor (NMDAr), which is expressed in VSMC and is involved in homocysteine effects in other cell types...
  33. ncbi The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents
    Isabella Russo
    Diabetes Unit, Department of Clinical and Biological Sciences of the Turin University, Ospedale San Luigi Gonzaga Hospital, Regione Gonzole, 10, Orbassano 10043, Turin, Italy
    Thromb Res 114:265-73. 2004
    ....
  34. ncbi Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect
    Giovanni Anfossi
    Diabetes Unit, Department of Clinical and Biological Sciences, University of Turin, Azienda Ospedaliera S Luigi, I 10043 Orbassano, Turin, Italy
    Thromb Res 105:71-8. 2002
    ..This effect plays a direct role in the adenosine-induced antiaggregation...
  35. ncbi Relevance of the vascular effects of insulin in the rationale of its therapeutical use
    Giovanni Anfossi
    Department of Clinical and Biological Sciences of the Turin University, San Luigi Gonzaga Hospital, I 10043 Orbassano Turin, Italy
    Cardiovasc Hematol Disord Drug Targets 7:228-49. 2007
    ..Aim of this review is to clarify whether the vascular effects of insulin could represent a new "rationale" for its therapeutical use, independently of the well known metabolic actions...
  36. doi Short-term mortality risk in children and young adults with type 1 diabetes: the population-based Registry of the Province of Turin, Italy
    G Bruno
    Department of Internal Medicine, University of Torino, Torino, Italy
    Nutr Metab Cardiovasc Dis 19:340-4. 2009
    ..The quality of diabetes care should be improved to prevent early deaths...
  37. ncbi Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits
    G Anfossi
    Metabolic Disease and Diabetes Unit, Department of Clinical and Biological Sciences of the University of Turin, San Luigi Gonzaga Hospital, Orbassano TO, Italy
    Nutr Metab Cardiovasc Dis 14:215-24. 2004
    ..In this review, we consider the role of liver in metabolism of statins, their potential hepatic toxicity and the guidelines for their prescription in patients affected by different liver diseases...
  38. ncbi White blood cell count is positively correlated with albumin excretion rate in subjects with type 2 diabetes
    Franco Cavalot
    Diabetes Unit, Department of Clinical and Biological Sciences of the University of Turin, San Luigi Gonzaga Hospital, Orbassano Turin, Italy
    Diabetes Care 25:2354-5. 2002
  39. ncbi Diabetic muscle infarction associated with multiple autoimmune disorders, IgA deficiency and a catastrophically poor glycaemic control: a case report
    A Ali
    Metabolic Diseases and Diabetes Unit, Department of Clinical and Biological Sciences, Turin University, San Luigi Gonzaga Hospital, Orbassano, Torino, Italy
    Diabetes Nutr Metab 16:134-7. 2003
    ....
  40. ncbi Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway
    Isabella Russo
    Diabetes Unit, Department of Clinical and Biological Sciences of the University of Turin, San Luigi Gonzaga Hospital, Orbassano Turin, Italy
    Clin Biochem 41:343-9. 2008
    ..Because the sGC/cGMP pathway is involved in the control of platelet aggregation, we investigated whether in human platelets NaN(3) influences the responses to agonists, cGMP levels and cGMP-regulated pathways...
  41. ncbi Homocysteine rapidly increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Role of phosphatidyl inositol 3-kinase and mitogen activated protein kinase pathways
    Gabriella Doronzo
    Diabetes Unit, Department of Clinical and Biological Sciences of the University of Turin, San Luigi Gonzaga Hospital, Orbassano Turin, Italy
    Thromb Haemost 94:1285-93. 2005
    ..These data suggest that homocysteine is directly involved in mechanisms leading to remodelling and instabilization of atherosclerotic plaques...
  42. doi Contribution of insulin resistance to vascular dysfunction
    Giovanni Anfossi
    Internal Medicine University Unit, San Luigi Gonzaga Faculty of Medicine and Department of Clinical and Biological Sciences, Turin University, San Luigi Gonzaga Hospital, 10043 Orbassano, Turin, Italy
    Arch Physiol Biochem 115:199-217. 2009
    ..Finally, we consider the influence of free fatty acids, cytokines and endothelin on vascular insulin resistance...
  43. doi Evaluation of a simple policy for pre- and post-prandial blood glucose self-monitoring in people with type 2 diabetes not on insulin
    Katia Bonomo
    San Luigi Gonzaga Faculty of Medicine of the Turin University, Department of Clinical and Biological Sciences, San Luigi Gonzaga Hospital, Italy
    Diabetes Res Clin Pract 87:246-51. 2010
    ..Since there is no agreement on regimens of self-monitoring of blood glucose (SMBG) in type 2 diabetes not on insulin, we evaluated the effects of a simple SMBG policy taking into account compliance...
  44. ncbi Pancreatic elastase-1 in stools, a marker of exocrine pancreas function, correlates with both residual beta-cell secretion and metabolic control in type 1 diabetic subjects
    Franco Cavalot
    University of Turin, San Luigi Gonzaga Hospital, Department of Clinical and Biological Sciences, Diabetes Unit, 10043 Orbassano TO, Turin, Italy
    Diabetes Care 27:2052-4. 2004
  45. ncbi Catecholamines, via beta-adrenoceptors, increase intracellular concentrations of 3',5'-cyclic guanosine monophosphate (cGMP) through nitric oxide in human platelets
    Giovanni Anfossi
    Thromb Haemost 87:539-40. 2002
  46. ncbi Incidence of type 1 and type 2 diabetes in adults aged 30-49 years: the population-based registry in the province of Turin, Italy
    Graziella Bruno
    Department of Internal Medicine, University of Turin corso Dogliotti 14, I 10126 Turin, Italy
    Diabetes Care 28:2613-9. 2005
    ..Incidence of type 1 diabetes is considered to be low in adults, but no study has been performed in Mediterranean countries...
  47. ncbi Does pancreatic elastase-1 in stools predict steatorrhea in type 1 diabetes?
    Franco Cavalot
    Diabetes Unit, Department of ClinicalBiological Sciences, University of Turin, San Luigi Gonzaga Hospital, 10043 Orbassano, Turin, Italy
    Diabetes Care 29:719-21. 2006
  48. ncbi Pancreatic elastase-1 in stools, a marker of exocrine pancreas function, correlates with both residual beta-cell secretion and metabolic control in type 1 diabetic subjects: response to Mueller et al
    Franco Cavalot
    Diabetes Care 28:2810-1. 2005
  49. ncbi Diabetes prevention strategy in offspring of type 2 diabetic patients with a direct involvement of the diseased parents
    Katia Bonomo
    Nutr Metab Cardiovasc Dis 15:237-8. 2005
  50. ncbi Type 2 diabetes and the Naaman syndrome
    Giulio Marchesini
    Diabetes Care 26:3195. 2003